Quantbot Technologies LP Uro Gen Pharma Ltd. Transaction History

Quantbot Technologies LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$7.55 - $11.9 $1,510 - $2,380	-200 Reduced 22.08%	706 $6,000
Q3 2022 Nov 07, 2022	SELL	$7.21 - $9.41 $8,652 - $11,292	-1,200 Reduced 56.98%	906 $7,000
Q2 2022 Aug 09, 2022	BUY	$5.12 - $8.74 $10,782 - $18,406	2,106 New	2,106 $17,000
Q4 2021 Feb 11, 2022	SELL	$9.03 - $19.13 $7,223 - $15,304	-800 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$14.31 - $18.39 $11,448 - $14,712	800 New	800 $13,000

Q1 2020 May 13, 2020	SELL	$13.68 - $34.6 $19,904 - $50,343	-1,455 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$21.11 - $34.86 $27,084 - $44,725	-1,283 Reduced 46.86%	1,455 $48,000
Q3 2019 Nov 12, 2019	BUY	$23.83 - $36.44 $29,501 - $45,112	1,238 Added 82.53%	2,738 $65,000
Q2 2019 Aug 13, 2019	BUY	$32.75 - $40.35 $49,125 - $60,525	1,500 New	1,500 $53,000
Q3 2018 Nov 13, 2018	SELL	$41.65 - $51.7 $153,563 - $190,617	-3,687 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$48.35 - $65.33 $8,171 - $11,040	169 Added 4.8%	3,687 $183,000
Q1 2018 May 11, 2018	BUY	$38.64 - $57.54 $135,935 - $202,425	3,518 New	3,518 $174,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.